| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000038031 |
| Receipt No. | R000043359 |
| Scientific Title | Evaluation of muscle fatigue relieving or recovery effect of propolis-containing food. |
| Date of disclosure of the study information | 2022/01/01 |
| Last modified on | 2021/03/11 (Ver. 2) |
| Basic information | ||
| Public title | Evaluation of muscle fatigue relieving or recovery effect of propolis-containing food. | |
| Acronym | Evaluation of muscle fatigue relieving or recovery effect of propolis-containing food. | |
| Scientific Title | Evaluation of muscle fatigue relieving or recovery effect of propolis-containing food. | |
| Scientific Title:Acronym | Evaluation of muscle fatigue relieving or recovery effect of propolis-containing food. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy subject | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We examine the relieving and recovery effect of propolis for muscle fatigue when the subjects take propolis for 1 weeks. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Muscle stiffness, voluntary muscle strength, and muscle activity are measured 1 week after intake. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Propolis
Intake:787.5 mg Ingesion:7 days |
|
| Interventions/Control_2 | Propolis
Intake:100 mg Ingesion:7 days |
|
| Interventions/Control_3 | placebo
Ingesion:7 days |
|
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1. Healthy Japanese men aged greater than or equal to 18 years, less than 35 years at the time of obtaining informed consent.
2. Subjects who can walk independently and can measure physical exercise performance. 3. Subjects who do not plan to change their lifestyle habits for a test period. |
|||
| Key exclusion criteria | 1. Subjects who have a history of asthma or current medical history.
2. Subjects who have allergies to bee products (honey etc.), conifers, trees of Pinaceae, poplar and salicylic acid. 3. Subjects who have serious illness or medical history such as diabetes, liver disease, kidney disease, heart disease. 4. Subjects who have medical history or history of food allergies or current medical history. 5. Others who judged that the investigator is inappropriate as the subject. |
|||
| Target sample size | 18 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shibaura Institute of Technology | ||||||
| Division name | Systems engineering and Science | ||||||
| Zip code | 337-8570 | ||||||
| Address | 307 Fukasaku,Minuma-ku, Saitama-shi, Saitama | ||||||
| TEL | 048-720-6021 | ||||||
| rakagi12@shibaura-it.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Shibaura Institute of Technology | ||||||
| Division name | Systems engineering and Science | ||||||
| Zip code | 337-8570 | ||||||
| Address | 307 Fukasaku,Minuma-ku, Saitama-shi, Saitama | ||||||
| TEL | 048-720-6021 | ||||||
| Homepage URL | |||||||
| rakagi12@shibaura-it.ac.jp | |||||||
| Sponsor | |
| Institute | Shibaura Institute of Technology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yamada Bee Company, Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Shibaura Institute of Technology Biotechnology Research Ethics Committee |
| Address | 3-7-5 Toyosu, Koto-ku, Tokyo |
| Tel | 03-5859-7340 |
| tgakuji@ow.shibaura-it.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043359 |